Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

Search Again »

Abstract Number: 1858 • 2017 ACR/ARHP Annual Meeting
Utilizing Needs Assessment Data to Establish Foundational Training for Adult and Pediatric Nurse Practitioners (NP) and Physician Assistants (PA) Entering Rheumatology Practice
Barbara Slusher^1,2, Jeanne Scott³, Christine A. Stamatos⁴, Benjamin J Smith^5,6,7, Elizabeth A. Schlenk⁸, Heather Benham⁹, Daniel Schaffer¹⁰ and Karen L. Smarr¹¹, ¹Physician Assistant Studies, University of Texas Medical Branch, Galveston, TX, ²Rheumatology, University of Texas Medical Branch, Galveston, TX, ³Rheumatology, Cheshire Medical Clinic, Keene, NH, ⁴Rheumatology, Northwell Health, Great Neck, NY, ⁵Rheumatology, Florida State University, Tallahassee, FL, ⁶Rheumatology, McIntosh Clinic, P.C., Thomasville, GA, ⁷School of Physician Assistant Practice, Florida State University College of Medicine, Tallahassee, FL, ⁸School of Nursing Room 415, University of Pittsburgh, Pittsburgh, PA, ⁹Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX, ¹⁰Rheumatology, Mayo Clinic, Rochester, MN, ¹¹Rheumatology Research, Harry S Truman Memorial VA Hospital, Columbia, MO
Background/Purpose: Rheumatology is a cognitive specialty requiring years of clinical exposure and hands-on training to manage complex patients. However, there is no current standardized training…
Abstract Number: 1913 • 2017 ACR/ARHP Annual Meeting
Inter-Omic Analysis Reveals Functional Relationship between Diverse Gut Microbiota and Dysregulated Host Immune Response in HLA-B27-Mediated Experimental Spondyloarthritis
Tejpal Gill¹, Stephen R. Brooks², Mark Asquith³, James T. Rosenbaum⁴ and Robert Colbert⁵, ¹National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ²Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS/NIH, Bethesda, MD, ³Oregon Health & Science University, Portland, OR, ⁴Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR, ⁵NIAMS/NIH, Bethesda, MD
Background/Purpose: HLA-B27 has been hypothesized to alter gut microbiota and host-microbe interactions to promote spondyloarthritis (SpA). In HLA-B27 transgenic (HLA-B27 Tg) rats with experimental SpA,…
Abstract Number: 1955 • 2017 ACR/ARHP Annual Meeting
Health Care Provider Advice for Weight Loss Among US Adults with Arthritis, National Health Interview Survey, 2014
Jennifer M. Hootman¹, Miriam G. Cisternas², Louise Murphy³ and Teresa J. Brady⁴, ¹Centers for Disease Control and Prevention, Kennesaw, GA, ²MGC Data Services, Carlsbad, CA, ³Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA, ⁴Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Most clinical practice guidelines for the management of osteoarthritis recommend weight loss for adults with arthritis who are overweight or obese. A health care…
Abstract Number: 2050 • 2017 ACR/ARHP Annual Meeting
Analysis of Data Collected from Right and Left Limbs: Accounting for Dependence and Improving Statistical Efficiency in Musculoskeletal Research
Sarah Stewart¹, Janet Pearson², Keith Rome³, Nicola Dalbeth⁴ and Alain Vandal⁵, ¹School of Podiatry, Auckland University of Technology, Auckland, New Zealand, ²Auckland University of Technology, Auckland, Niger, ³School of Clinical Sceince, Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand, ⁴University of Auckland, Auckland, New Zealand, ⁵Counties Manukau District Health Board, Auckland, New Zealand
Background/Purpose: Statistical techniques used in musculoskeletal research often inefficiently account for paired-limb measurements or the relationship between measurements taken from multiple sites within limbs. This…
Abstract Number: 2053 • 2017 ACR/ARHP Annual Meeting
Computed Tomography Dependent Diagnosis of Crowned Dens Syndrome; A Cervical Manifestation of Patients with Calcium Pyrophosphate Dihydrate Crystal Deposition Disease
Ammar Haikal¹, Brian Everist², Pim Jetanalin³ and Mehrdad Maz³, ¹Department Internal Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, ²Department of Radiology (MSK), Department of Radiology (MSK), University of Kansas Medical Center, Kansas City, KS, ³Allergy, Clinical Immunology, and Rheumatology, Division of Allergy, Clinical Immunology and Rheumatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
Background/Purpose: Crowned Dens Syndrome (CDS), a variation of Calcium Pyrophosphate Deposition Disease (CPPD), is a radiologic-clinical entity defined by the association of radiological calcifications around…
Abstract Number: 2057 • 2017 ACR/ARHP Annual Meeting
Identification of Urate Deposits in Patients with Asymptomatic Hyperuricemia Using a Dual-Energy CT Scan
Penny Wang¹, Stacy Smith², Rajesh Garg³, Fengxin Lu¹, Alyssa Wohlfahrt¹, Anarosa Campos¹, Kathleen Vanni⁴, Zhi Yu⁵, Daniel H. Solomon¹ and Seoyoung C. Kim¹, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Radiology, Division of Musculoskeletal Imaging and Intervention, Brigham and Women's Hospital, Boston, MA, ³Division of Endocrinology, Diabetes & Hypertension, Brigham and Women's Hospital, Boston, MA, ⁴Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁵Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Serum uric acid (sUA) is a useful indicator of the risk of developing gout. However, most patients with elevated sUA levels do not have…
Abstract Number: 2061 • 2017 ACR/ARHP Annual Meeting
Population-Specific Factors Associated with Fractional Excretion of Uric Acid
Zoe Vincent¹, Amanda Phipps-Green², Lisa K. Stamp³, Tony R. Merriman⁴ and Nicola Dalbeth¹, ¹University of Auckland, Auckland, New Zealand, ²University of Otago, Dunedin, New Zealand, ³University of Otago, Christchurch, New Zealand, ⁴Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand
Background/Purpose: For most people with gout, reduced renal clearance of uric acid is a key contributor to hyperuricemia. It is increasingly recognized that gout has…
Abstract Number: 2071 • 2017 ACR/ARHP Annual Meeting
A Novel Selective URAT1 Inhibitor, Tei-a, with Potent Uricosuric Property
Johji Nomura¹, Yoshimasa Takahashi², Kumiko Aoki², Naoki Hase² and Tsunefumi Kobayashi², ¹Teijin Institute for Bio-medical Research, TEIJIN PHARMA LIMITED, Tokyo, Japan, ²TEIJIN PHARMA LIMITED, Tokyo, Japan
Background/Purpose: Hyperuricemia, abnormally elevated level of serum uric acid, is associated with gout as well as other diseases including metabolic syndrome, hypertension, diabetic kidney disease.…
Abstract Number: 2072 • 2017 ACR/ARHP Annual Meeting
A Pharmacokinetic and Pharmacodynamic Evaluation of URC102, a Potent and Selective Inhibitor of URAT1, after Single and Multiple Oral Administrations in Healthy Volunteers
Hyun A Lee¹, Sang-In Park¹, Seonghae Yoon², Makoto Onohara³, Jeongeun Choi⁴, Kyung-Sang Yu¹ and Howard Lee¹, ¹Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Korea, Republic of (South), ²Clinical Trials Center, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South), ³Science and Strategy, Translational Clinical Research, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan, ⁴JW Pharmaceutical Corporation, Seoul, Korea, Republic of (South)
Background/Purpose: URC102, a novel and potent inhibitor of human uric acid transporter 1 (hURAT1), is currently under clinical development to treat patients with gout. In…
Abstract Number: 2078 • 2017 ACR/ARHP Annual Meeting
Hypersensitivity Reactions with Allopurinol and Febuxostat in Adults 65 Years or Older: A Study Using the Medicare Claims Data
Jasvinder A. Singh¹ and John Cleveland², ¹Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL
Background/Purpose: Clinicians using allopurinol are always concerned about the risk of rare hypersensitivity reaction. Allopurinol and febuxostat are the two most common urate-lowering agents used…
Abstract Number: 2080 • 2017 ACR/ARHP Annual Meeting
Serum Uric Acid and Incident Dementia: A Population Based Study
Lieke E.J.M. Scheepers¹, Mats Dehlin¹, Lennart TH Jacobsson¹, Lena Johansson² and Ingmar Skoog², ¹Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ²Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Background/Purpose: Elevated serum uric acid (sUA) is an established risk factor for gout. Its role in the development of dementia is controversial, low levels of…
Abstract Number: 2081 • 2017 ACR/ARHP Annual Meeting
Synovial Fluid Leukocyte Count and Its Association with Crystal Deposition in Asymptomatic Hyperuricemia
Mariano Andrés^1,2, José Antonio Bernal³, María Dolores Arenas⁴ and Eliseo Pascual^1,5, ¹Sección de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain, ²Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain, ³Reumatología, Hospital Universitario del Vinalopó, Elche, Spain, ⁴Unidad de Nefrología, Hospital Vithas Perpetuo Socorro, Alicante, Spain, ⁵Emeritus Professor, Universidad Miguel Hernández, Elche, Spain
Background/Purpose: Articular and periarticular deposits of monosodium urate (MSU) crystals in asymptomatic hyperuricemia (AH) may associate with more severe forms of atherosclerosis [Andrés 2016]. This…
Abstract Number: 2088 • 2017 ACR/ARHP Annual Meeting
Clinical Significance of Urate Deposition in Tendon: A Dual-Energy CT Study
In Young Kim¹, Yeonghee Eun², Ji young Chai³, Chan Hong Jeon⁴, Jinseok Kim⁵, Hyungjin Kim², Jaejoon Lee¹, Eun-Mi Koh² and Hoon-Suk Cha⁶, ¹Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), ²Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), ³Department of Rheumatology, Bundang Jesaeng Hospital, Seongnam, Korea, Republic of (South), ⁴Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea, Republic of (South), ⁵Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea, Republic of (South), ⁶Department of Medicine,Division of Rheumatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
Background/Purpose: Dual-energy computed tomography (DECT) is advanced imaging modality that shows the deposition of monosodium urate (MSU) crystal in tissue as a color signal. In…
Abstract Number: 2089 • 2017 ACR/ARHP Annual Meeting
Arhalofenate Acid Inhibits Urate Crystal-Induced Inflammatory Responses through Activation of AMP-Activated Protein Kinase (AMPK) Signaling
Charles McWherter¹, Robert Terkeltaub^2,3 and Ru Liu-Bryan^3,4, ¹CymaBay Therapeutics, Inc., Newark, CA, ²Rheumatology, VA San Diego Healthcare System, San Diego, CA, ³Medicine-Rheumatology, University of California, San Diego, La Jolla, CA, ⁴VA San Diego Healthcare System, San Diego, CA
Background/Purpose: Arhalofenate is an investigational drug with dual uricosuric and anti-inflammatory properties. Arhalofenate reduced the risk of acute flare while lowering serum urate levels in…
Abstract Number: 2090 • 2017 ACR/ARHP Annual Meeting
Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with Veterans Affairs Medical Center
Julianna Desmarais¹ and Cong-Qiu Chu², ¹Department of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, ²Rheumatology, Oregon Health & Science University, Portland, OR
Background/Purpose: Anakinra is an IL-1 blocking medication used off label to relieve acute inflammation from gout and pseudogout. The efficacy and safety of this treatment…

Search Again »

Didn't find what you were looking for? Try the Advanced Search »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].